Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Therapy for cryptococcal meningitis in patients with AIDS
William G. Powderly
Division of Infectious Diseases
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Department of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
88
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapy for cryptococcal meningitis in patients with AIDS'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cryptococcal Meningitis
100%
Fluconazole
100%
Amphotericin B
75%
Cerebrospinal Fluid
50%
Flucytosine
50%
Cryptococcal Infection
50%
Risk Factors
25%
Response Rate
25%
Failure Rate
25%
Itraconazole
25%
Highly Effective
25%
Poor Outcome
25%
Titer
25%
High Titer
25%
Primary Therapy
25%
Recurrent Disease
25%
Leukocyte Count
25%
Lethargy
25%
Suppressive Therapy
25%
Cryptococcosis
25%
Primary Prophylaxis
25%
Obtundation
25%
Cryptococcal Antigen
25%
Triazole Antifungal Agents
25%
Medicine and Dentistry
Cryptococcal Meningitis
100%
Fluconazole
100%
Amphotericin B
75%
Cerebrospinal Fluid
50%
Flucytosine
50%
Infection
25%
Leukocyte
25%
Recurrent Disease
25%
Itraconazole
25%
Cryptococcosis
25%
Antifungal Agent
25%
Obtundation
25%
Diseases
25%
Triazole
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cryptococcal Meningitis
100%
Fluconazole
100%
Amphotericin B
75%
Flucytosine
50%
Infection
25%
Itraconazole
25%
Recurrent Disease
25%
Antifungal Agent
25%
Cryptococcosis
25%
Diseases
25%
Triazole
25%